Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-10-14 Sale | 2025-10-16 4:01 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 28,918 | $3.9623 | $114,581 | 67,006 (Direct) | View |
2025-08-27 Purchase | 2025-08-27 8:54 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 10,000 | $3.41 | $34,100 | 40,000 (Direct) | View |
2025-08-18 Sale | 2025-08-20 5:00 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 1,060 | $3.0415 | $3,224 | 55,924 (Direct) | View |
2025-08-18 Sale | 2025-08-20 5:00 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 2,485 | $3.0426 | $7,561 | 221,609 (Direct) | View |
2025-08-18 Sale | 2025-08-20 5:00 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 1,592 | $3.0395 | $4,839 | 135,462 (Direct) | View |
2025-08-14 Sale | 2025-08-18 4:35 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 11,161 | $3.019 | $33,695 | 224,094 (Direct) | View |
2025-08-14 Sale | 2025-08-18 4:35 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 7,043 | $3.019 | $21,263 | 56,984 (Direct) | View |
2025-08-14 Sale | 2025-08-18 4:35 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 12,109 | $3.019 | $36,557 | 137,054 (Direct) | View |
2025-07-03 Sale | 2025-07-08 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Ondrey Aaron Chief Financial Officer | 1,477 | $2.882 | $4,257 | 128,173 (Direct) | View |
2025-05-20 Sale | 2025-05-22 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 357 | $6.446 | $2,301 | 64,027 (Direct) | View |
2025-05-20 Sale | 2025-05-22 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 801 | $6.446 | $5,163 | 235,255 (Direct) | View |
2025-05-20 Sale | 2025-05-22 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 767 | $6.446 | $4,944 | 573,628 (Indirect Direct) | View |
2025-05-20 Sale | 2025-05-22 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 2,253 | $6.446 | $14,523 | 1,193,044 (Indirect Direct) | View |
2025-05-20 Sale | 2025-05-22 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 587 | $6.446 | $3,784 | 149,163 (Direct) | View |
2025-05-16 Sale | 2025-05-20 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 655 | $6.528 | $4,276 | 64,384 (Direct) | View |
2025-05-16 Sale | 2025-05-20 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 1,409 | $6.528 | $9,198 | 574,395 (Indirect Direct) | View |
2025-05-16 Sale | 2025-05-20 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 1,582 | $6.528 | $10,327 | 236,056 (Direct) | View |
2025-05-16 Sale | 2025-05-20 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 3,621 | $6.528 | $23,638 | 1,195,297 (Indirect Direct) | View |
2025-05-16 Sale | 2025-05-20 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 946 | $6.528 | $6,175 | 149,750 (Direct) | View |
2025-04-22 Sale | 2025-04-24 4:06 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 718 | $7.158 | $5,139 | 65,039 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-10-06 Option Award | 2025-10-08 3:39 pm | 2028-10-06 2035-10-06 | ROCKET PHARMACEUTICALS INC. | RCKT | Rizvi Syed Ali-aamir Chief Medical Officer | 729,765 | $0 | 729,765 (Direct) | View |
2025-09-24 Option Award | 2025-10-03 8:33 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Fong Peter Director | 53,333 | $0 | 53,333 (Direct) | View |
2025-09-19 Exercise | 2025-09-23 4:21 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See remarks 10% Owner | 41,000 | $19.09 | 19,336,124 (Indirect) | View |
2025-09-19 Exercise | 2025-09-23 4:21 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See remarks 10% Owner | 59,000 | $17.81 | 19,336,124 (Indirect) | View |
2025-09-19 Exercise | 2025-09-23 4:21 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See remarks 10% Owner | 1,000,000 | $40.03 | 19,336,124 (Indirect) | View |
2025-09-19 Other | 2025-09-23 4:21 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See remarks 10% Owner | 1,100,000 | $3.105 | 19,336,124 (Indirect) | View |
2025-09-19 Exercise | 2025-09-23 4:21 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See remarks 10% Owner | 3 | $0 | 19,336,124 (Indirect) | View |
2025-09-08 Option Award | 2025-09-09 4:22 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 40,000 | $0 | 95,924 (Direct) | View |
2025-09-08 Option Award | 2025-09-09 4:18 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 150,000 | $0 | 285,462 (Direct) | View |
2025-09-08 Option Award | 2025-09-09 4:15 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 80,000 | $0 | 301,609 (Direct) | View |
2025-08-18 Tax Withholding | 2025-08-20 5:00 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 2,234 | $3.05 | 1,190,810 (Direct) | View |
2025-08-04 Option Award | 2025-08-06 4:11 pm | N/A 2035-08-04 | ROCKET PHARMACEUTICALS INC. | RCKT | Stevens Christopher James Chief Operating Officer | 961,237 | $0 | 961,237 (Direct) | View |
2025-06-18 Option Award | 2025-07-18 4:05 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Pratumsuwan Piratip Director | 30,000 | $0 | 30,000 (Direct) | View |
2025-06-18 Option Award | 2025-07-18 4:05 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | GRANADILLO PEDRO P Director | 54,734 | $0 | 54,734 (Direct) | View |
2025-06-18 Option Award | 2025-07-18 4:05 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Dolsten Mikael Director | 30,000 | $0 | 44,220 (Direct) | View |
2025-06-18 Option Award | 2025-07-18 4:05 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | WONG RODERICK Director 10% Owner | 47,667 | $0 | 18,236,124 (Direct) | View |
2025-06-18 Option Award | 2025-07-18 4:05 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director | 49,434 | $0 | 1,036,846 (Indirect) | View |
2025-06-18 Option Award | 2025-07-18 4:05 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Malik Fady Ibraham Director | 30,000 | $0 | 30,000 (Direct) | View |
2025-06-18 Option Award | 2025-07-18 4:05 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | BOESS CARSTEN Director | 30,000 | $0 | 30,000 (Direct) | View |
2025-06-18 Option Award | 2025-07-18 4:05 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 30,000 | $0 | 30,000 (Direct) | View |
2025-06-18 Option Award | 2025-07-18 4:05 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | SOUTHWELL DAVID P Director | 30,000 | $0 | 144,784 (Direct) | View |